The latest price target for Silk Road Medical (NASDAQ:SILK) was reported by Stifel on July 17, 2024. The analyst firm set a price target for $27.50 expecting SILK to rise to within 12 months (a possible 1.44% upside). 18 analyst firms have reported ratings in the last year.

The latest analyst rating for Silk Road Medical (NASDAQ:SILK) was provided by Stifel, and Silk Road Medical downgraded their hold rating.

The last upgrade for Silk Road Medical Inc happened on March 7, 2024 when Argus Research raised their price target to $24. Argus Research previously had a hold for Silk Road Medical Inc.

The last downgrade for Silk Road Medical Inc happened on July 17, 2024 when Stifel changed their price target from $23 to $27.5 for Silk Road Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Silk Road Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Silk Road Medical was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.

While ratings are subjective and will change, the latest Silk Road Medical (SILK) rating was a downgraded with a price target of $23.00 to $27.50. The current price Silk Road Medical (SILK) is trading at is $27.11, which is within the analyst’s predicted range.